The isolated perfused rat heart preparation was used to investigate the interrelationship between temperature and the ability of calcium antagonists to reduce protein leakage in the calcium paradox. Exploiting the fact that although the calcium depletion phase of calcium paradox-injury is highly temperature sensitive, the calcium repletion phase, during which time the injury is manifested, is temperature independent. Verapamil (4 mumol l-1) included in a 10 min period of calcium depletion (37 degrees C) and a 20 min period of calcium repletion (37 degrees C) was known to reduce cumulative protein leakage by 22 +/- 3%. With calcium depletion again at 37 degrees C but repletion at 21 degrees C verapamil failed to achieve any reduction in protein leakage despite the fact that leakage in the 21 degrees C control group did not differ significantly from that in the 37 degrees C control group. Temperature-response studies (repletion temperature of 4, 10, 21, 23, 25, 28, 31, 34 and 37 degrees C) revealed an abrupt loss of drug effect below 25 degrees C. Studies with D600 (10 mumol l-1), nifedipine (4 mumol l-1), terodiline (4 mumol l-1) fendiline (20 mumol l-1) and diltiazem (2 mumol l-1) revealed that while all of these drugs reduced protein leakage at 37 degrees C (24 +/- 3%, 31 +/- 2%, 31 +/- 3%, 23 +/- 3% and 29 +/- 3%, respectively), like verapamil they had no effect at 21 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/eurheartj/4.suppl_h.97 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!